- Skopje, North Macedonia -
There is increasing recognition that terrorists can benefit from organized crime, whether domestic or transnational, through trafficking in arms, persons, drugs, cultural property, the illicit exploitation and trafficking of natural resources such as oil, precious metals and minerals, as well as timber, charcoal, and wildlife, the abuse of legitimate commercial enterprise, non-profit organizations, external donations, crowdfunding and proceeds of criminal activity, including kidnapping for ransom, extortion, bank robbery, as well as transnational organized crime at sea.
Chemical, biological, radiological, and nuclear (CBRN) disinformation is defined as intentionally misleading and deceptive information about CBRN threats that can potentially cause serious political, financial, and physical harm to governments, international organizations, the scientific community, academia, industry, and the population at large.
In the last decades, many terrorist attacks were perpetrated in public places against soft targets. Attacks occurring during sports events are particularly hideous as sports have historically played a significant role in the dissemination of positive values across civilizations and cultures, especially for young people.
The proliferation of chemical, biological, radiological, and nuclear (CBRN) weapons, materials and their means of delivery represents a pressing threat to international peace and security. Actors involved in the financing of such activities look to exploit loopholes in the global financial system to move and raise funds to develop CBRN programmes.
UNICRI, in cooperation with the United States Federal Bureau of Investigation, administers the International Network on Biotechnology (INB), a global network of academic and research institutions committed to advancing education and raising awareness about responsible life science. The INB experts exchange views and possible actions to support governments and relevant sectors of civil society (including academia, research institutions, technology companies) with a focus on emerging developments in the life sciences and biotechnology.